177 related articles for article (PubMed ID: 29473952)
1. Biophysical and structural insight into the USP8/14-3-3 interaction.
Centorrino F; Ballone A; Wolter M; Ottmann C
FEBS Lett; 2018 Apr; 592(7):1211-1220. PubMed ID: 29473952
[TBL] [Abstract][Full Text] [Related]
2. USP8: a novel therapeutic target for Cushing's disease.
Jian F; Cao Y; Bian L; Sun Q
Endocrine; 2015 Nov; 50(2):292-6. PubMed ID: 26162929
[TBL] [Abstract][Full Text] [Related]
3. Recurrent gain-of-function USP8 mutations in Cushing's disease.
Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
[TBL] [Abstract][Full Text] [Related]
4. USP8 mutation in Cushing's disease.
Huang C; Shi Y; Zhao Y
Oncotarget; 2015 Jul; 6(21):18240-1. PubMed ID: 26285834
[No Abstract] [Full Text] [Related]
5. Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract][Full Text] [Related]
6. Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
Theodoropoulou M; Reincke M; Fassnacht M; Komada M
Eur J Endocrinol; 2015 Oct; 173(4):M73-83. PubMed ID: 26012588
[TBL] [Abstract][Full Text] [Related]
7. The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease.
Perez-Rivas LG; Theodoropoulou M; Ferraù F; Nusser C; Kawaguchi K; Stratakis CA; Faucz FR; Wildemberg LE; Assié G; Beschorner R; Dimopoulou C; Buchfelder M; Popovic V; Berr CM; Tóth M; Ardisasmita AI; Honegger J; Bertherat J; Gadelha MR; Beuschlein F; Stalla G; Komada M; Korbonits M; Reincke M
J Clin Endocrinol Metab; 2015 Jul; 100(7):E997-1004. PubMed ID: 25942478
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
Reincke M; Sbiera S; Hayakawa A; Theodoropoulou M; Osswald A; Beuschlein F; Meitinger T; Mizuno-Yamasaki E; Kawaguchi K; Saeki Y; Tanaka K; Wieland T; Graf E; Saeger W; Ronchi CL; Allolio B; Buchfelder M; Strom TM; Fassnacht M; Komada M
Nat Genet; 2015 Jan; 47(1):31-8. PubMed ID: 25485838
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of ubiquitin-specific protease 8 autoinhibition by the WW-like domain.
Kakihara K; Asamizu K; Moritsugu K; Kubo M; Kitaguchi T; Endo A; Kidera A; Ikeguchi M; Kato A; Komada M; Fukushima T
Commun Biol; 2021 Nov; 4(1):1272. PubMed ID: 34750505
[TBL] [Abstract][Full Text] [Related]
10. Genetics of Cushing's disease: an update.
Perez-Rivas LG; Reincke M
J Endocrinol Invest; 2016 Jan; 39(1):29-35. PubMed ID: 26208471
[TBL] [Abstract][Full Text] [Related]
11. Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8·STAM complex.
Berlin I; Schwartz H; Nash PD
J Biol Chem; 2010 Nov; 285(45):34909-21. PubMed ID: 20736164
[TBL] [Abstract][Full Text] [Related]
12. The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.
Hayashi K; Inoshita N; Kawaguchi K; Ibrahim Ardisasmita A; Suzuki H; Fukuhara N; Okada M; Nishioka H; Takeuchi Y; Komada M; Takeshita A; Yamada S
Eur J Endocrinol; 2016 Feb; 174(2):213-26. PubMed ID: 26578638
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions.
Dufner A; Knobeloch KP
Biochem Soc Trans; 2019 Dec; 47(6):1867-1879. PubMed ID: 31845722
[TBL] [Abstract][Full Text] [Related]
14. USP8 Mutations and Cell Cycle Regulation in Corticotroph Adenomas.
Martins CS; Camargo RC; Coeli-Lacchini FB; Saggioro FP; Moreira AC; de Castro M
Horm Metab Res; 2020 Feb; 52(2):117-123. PubMed ID: 32053843
[TBL] [Abstract][Full Text] [Related]
15. Feasibility analysis of ACTH adenoma model in USP8-/- mice.
Li J; Wu N; Zhu D; Zhu Y
Endokrynol Pol; 2023; 74(2):181-189. PubMed ID: 36916541
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma.
Kim Y; Shiba-Ishii A; Nakagawa T; Husni RE; Sakashita S; Takeuchi T; Noguchi M
Pathol Int; 2017 Jun; 67(6):292-301. PubMed ID: 28544031
[TBL] [Abstract][Full Text] [Related]
17. The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation.
Meijer IM; Kerperien J; Sotoca AM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Apr; 25(4):919-30. PubMed ID: 23333852
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific protease 8 inhibitor suppresses adrenocorticotropic hormone production and corticotroph tumor cell proliferation.
Kageyama K; Asari Y; Sugimoto Y; Niioka K; Daimon M
Endocr J; 2020 Feb; 67(2):177-184. PubMed ID: 31666445
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing.
Sesta A; Cassarino MF; Terreni M; Ambrogio AG; Libera L; Bardelli D; Lasio G; Losa M; Pecori Giraldi F
Neuroendocrinology; 2020; 110(1-2):119-129. PubMed ID: 31280266
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity.
Shichi H; Fukuoka H; Kanzawa M; Yamamoto M; Yamamoto N; Suzuki M; Urai S; Matsumoto R; Kanie K; Fujita Y; Bando H; Iguchi G; Inoshita N; Yamada S; Takahashi Y; Ogawa W
Pituitary; 2022 Jun; 25(3):496-507. PubMed ID: 35451730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]